Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,699,200 | 1,908,900 | 1,074,400 | 1,049,900 | 2,287,900 |
| Receivables | 1,536,200 | 1,627,100 | 1,999,700 | 1,664,100 | 1,781,400 |
| Inventories | 2,469,200 | 2,506,100 | 2,516,800 | 2,527,400 | 2,982,400 |
| Other current assets | 1,125,900 | 1,066,400 | 1,165,300 | 1,617,900 | 1,402,400 |
| TOTAL | $6,830,500 | $7,108,500 | $6,756,200 | $6,859,300 | $8,454,100 |
| Non-Current Assets | |||||
| PPE Net | 3,210,900 | 3,249,300 | 3,275,300 | 3,309,700 | 3,301,600 |
| Investments And Advances | 631,400 | 681,500 | 697,600 | 745,000 | 754,700 |
| Intangibles | 16,291,300 | 14,460,300 | 14,512,100 | 14,582,200 | 14,152,100 |
| Other Non-Current Assets | 1,349,100 | 1,304,500 | 1,326,400 | 1,348,600 | 1,530,700 |
| TOTAL | $21,482,700 | $19,695,600 | $19,811,400 | $19,985,500 | $19,739,100 |
| Total Assets | $28,313,200 | $26,804,100 | $26,567,600 | $26,844,800 | $28,193,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 422,700 | 354,500 | 387,000 | 403,300 | 440,100 |
| Accrued Expenses | 2,755,100 | 2,472,100 | 2,354,600 | 2,623,600 | 3,838,400 |
| TOTAL | $5,425,000 | $3,108,200 | $3,222,800 | $3,434,300 | $5,022,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,545,800 | 6,292,000 | 6,290,100 | 6,788,200 | 6,786,400 |
| aiOther Non-Current Liabilities | 1,101,100 | 924,200 | 1,183,600 | 1,181,900 | 1,176,900 |
| TOTAL | $6,529,300 | $7,806,800 | $8,131,800 | $8,611,100 | $8,691,200 |
| Total Liabilities | $11,954,300 | $10,915,000 | $11,354,600 | $12,045,400 | $13,713,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,719 | 145,662 | 145,597 | 145,361 | 144,898 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 18,993,100 | 18,604,600 | 18,021,000 | 17,627,600 | 17,377,900 |
| Other shareholders' equity | -145,800 | -146,100 | -160,600 | -153,800 | -163,500 |
| TOTAL | $16,358,900 | $15,889,100 | $15,213,000 | $14,799,400 | $14,479,700 |
| Total Liabilities And Equity | $28,313,200 | $26,804,100 | $26,567,600 | $26,844,800 | $28,193,200 |